Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Naphthyridines which affect IL-4 and G-CSF

Naphthyridines which affect IL-4 and G-CSF

US Patent 5939431 · Granted Aug 17, 1999

Estimated economic value: $137,934,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum2024
Methods, devices and systems for sensing, measuring and/or characterizing vessel2019
Blank, carton and package with dual access feature2019
Spin-to-open atherectomy device with electric motor control2018
C20-C21 substituted glucocorticoid receptor agonists2013
Method for treating atherosclerosis by administering human MCP1 fusions2012
Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusi2011
Treatment of chemokine mediated diseases2011
Treatment of chemokine mediated diseases2011
Substituted aniline derivatives useful as histamine H3 antagonists2011
Heteroatom-linked substituted piperidines and derivatives thereof useful as hist2010
Electrotransport device having an integrally molded reservoir housing2010